Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia Spectrum & Other Psychotic Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00173069
What this trial is testing

A Study on Psychopathological Progress of Early Schizophrenia-Like Disorder (SOPRES)

Who this might be right for
Schizophrenia
National Taiwan University Hospital 324
Large-scale testing (Phase 3)Study completedNCT01683058
What this trial is testing

Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 74
Not applicableLooking for participantsNCT05671185
What this trial is testing

RTMS for Depressive, Positive and Negative Symptoms, and Physiological Indices of Schizophrenia Patients

Who this might be right for
Schizophrenia and Related Disorders
National Taiwan University Hospital 180
Not applicableStudy completedNCT04870996
What this trial is testing

RCT of tDCS Combined With Cognitive Training in Schizophrenia

Who this might be right for
Schizophrenia
CHAN SAU MAN, SANDRA 44
Not applicableActive Not RecruitingNCT05905003
What this trial is testing

AMP SCZ® Observational Study: PREDICT-DPACC

Who this might be right for
Clinical High RiskPsychosisRemission+1 more
Brigham and Women's Hospital 2,617
Not applicableStudy completedNCT05660070
What this trial is testing

Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness

Who this might be right for
SchizophreniaSchizoaffective DisorderMood Disorder, Psychotic
University of California, San Diego 46
Not applicableUnknownNCT05599373
What this trial is testing

Optimal rTMS for Cognitive Deficits and Negative Symptoms in Schizophrenia

Who this might be right for
SchizophreniaNegative Symptoms in SchizophreniaCognitive Impairment+2 more
Shanghai Mental Health Center 90
Testing effectiveness (Phase 2)Study completedNCT02281773
What this trial is testing

Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment.

Who this might be right for
Schizophrenia
Boehringer Ingelheim 518
Large-scale testing (Phase 3)UnknownNCT01672554
What this trial is testing

Clinical Benefits of Seroquel XR in Anxiety Disorder

Who this might be right for
SchizophreniaAnxiety
Corporation de Recherche en Neuropsycho Pharmacologie de Quebec 40
Not applicableEnded earlyNCT05167396
What this trial is testing

REtinal and VIsual Cortical Response in Early PSYchosis

Who this might be right for
Prodromal SchizophreniaPsychotic EpisodeProdromal Symptoms+1 more
Centre Psychothérapique de Nancy 34
Testing effectiveness (Phase 2)Ended earlyNCT00669903
What this trial is testing

Study to Asses Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of AZD0328 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 100
Testing effectiveness (Phase 2)Ended earlyNCT00548327
What this trial is testing

The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype

Who this might be right for
SchizophreniaMemory DisordersCognition Disorders
National Institute of Mental Health (NIMH) 11
Early research (Phase 1)Study completedNCT06276361
What this trial is testing

Pharmacokinetics, Safety and Tolerability of Different Formulations and Dose Strengths of Quarterly Risperidone (QUAR) in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Rovi Pharmaceuticals Laboratories 58
Not applicableUnknownNCT00172770
What this trial is testing

The Establishment of the Early Intervention Program for Patients With Schizophrenia

Who this might be right for
Schizophrenia
National Taiwan University Hospital 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06442462
What this trial is testing

Study of SPG302 in Adults With Schizophrenia

Who this might be right for
Schizophrenia
Spinogenix 32
Early research (Phase 1)Study completedNCT04306146
What this trial is testing

Study of CAD-9303 in Subjects With Schizophrenia

Who this might be right for
Schizophrenia
Cadent Therapeutics 103
Not applicableStudy completedNCT00144027
What this trial is testing

Patient-Centered Medication Adherence Intervention for Schizophrenia

Who this might be right for
Schizophrenia
US Department of Veterans Affairs 75
Post-approval studies (Phase 4)Study completedNCT01481883
What this trial is testing

Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
The Alfred 13
Post-approval studies (Phase 4)Study completedNCT01284959
What this trial is testing

Different Safety Profile of Risperidone and Paliperidone Extended-release

Who this might be right for
Schizophrenia
Chonbuk National University Hospital 34
Not applicableStudy completedNCT04748679
What this trial is testing

Cognitive Behavioral Therapy (CBT) Study Evaluating the Updating of Persecutory Beliefs

Who this might be right for
Schizophrenia; PsychosisPersecutory Delusion
Vanderbilt University Medical Center 62
Next Page